活血豁痰法防治急性脑出血后脑积水的多中心、前瞻性、队列研究OA北大核心CSTPCD
A multicenter prospective cohort study on the prevention and treatment of hydrocephalus after acute intracerebral hemorrhage by promoting blood circulation and eliminating phlegm
目的 评价活血豁痰法防治急性脑出血后脑积水患者的临床疗效.方法 收集 2019 年9 月—2023 年6 月就诊于成都中医药大学附属医院、广元市中医医院、川北医学院附属医院、眉山市中医医院、叙永县中医医院的急性脑出血患者,共 139 例.采用队列研究设计,将"使用活血豁痰法"作为暴露因素,符合此暴露因素的患者分入中西医结合队列,不符合此暴露因素的患者分入西医队列.比较2 个队列脑出血后脑积水的临床疗效、脑出血后脑积水发生率、侧脑室前角间最大距离与尾状核头间最大距离之和(Huckman值)、血肿大小、终点事件发生率、美国国立卫生研究院卒中量表(NIHSS)评分、改良 Rankin 量表(mRS)评分、日常生活能力指数(Barthel 指数)评分.结果 2 个队列合并脑积水患者的临床总有效率分别为 60.0%、75.0%,中西医结合队列总有效率高于西医队列(P<0.05).治疗 28 d 后,中西医结合队列患者的脑积水发生率低于西医队列,Huckman值较西医队列下降(P<0.05).与发病24 h比较,2 个队列治疗28 d后血肿均缩小;与西医队列比较,中西医结合队列患者血肿缩小(均P<0.05).发病 6 个月后,中西医结合队列的死亡人数较西医队列减少(P<0.05).与治疗28 d比较,2 个队列患者 6 个月后的NIHSS评分、mRS评分降低,Barthel 指数评分升高;与西医队列比较,中西医结合队列患者在治疗 28 d、6 个月后的NIHSS评分、mRS评分均下降,Barthel指数评分升高(均P<0.05).结论 活血豁痰法能有效防治脑出血后脑积水,且不增加24 h内出血风险.
Objective We aimed to evaluate the clinical efficacy of promoting blood circulation and eliminating phlegm method in preventing and treating patients with hydrocephalus after acute intracerebral hemorrhage.Methods This study included 139 patients with acute intracerebral hemorrhage who visited Affiliated Hospital of Chengdu University of Traditional Chinese Medicine,Guangyuan Hospital of Traditional Chinese Medicine,Affiliated Hospital of North Sichuan Medical College,Meishan Hospital of Traditional Chinese Medicine,and Xuyong Hospital of Traditional Chinese Medicine from September 2019 to June 2023.Patients who met the exposure factors of"using the method of promoting blood circulation and eliminating phlegm"were classified into the integrated Chinese and Western medicine cohort,while those who did not meet the exposure factors were classified into the Western medicine cohort.Clinical efficacy,incidence of hydrocephalus after intracerebral hemorrhage,sum of maximum distance between the anterior horn of the lateral ventricle and the head of the caudate nucleus(Huckman value),size of the hematoma,incidence of endpoint events,National Institutes of Health Stroke Scale(NIHSS)score,Modified Rankin Scale(mRS)score,and Barthel index score between two cohorts were compared.Results Total clinical effective rates for patients with hydrocephalus in the two cohorts were 60.0%and 75.0%,respectively.The total effective rate of the integrated Chinese and Western medicine cohort was higher than that of the Western medicine cohort(P<0.05).After 28 days of treatment,the incidence of hydrocephalus in patients in the integrated Chinese and Western medicine cohort was lower than that of the Western medicine cohort,and the Huckman value decreased compared with the Western medicine cohort(P<0.05).Compared with 24 hours after onset,both cohorts showed a reduction in hematoma size after 28 days of treatment;compared with the Western medicine cohort,patients in the integrated Chinese and Western medicine cohort had reduced hematoma size(P<0.05).After 6 months of onset,the number of deaths in the integrated Chinese and Western medicine cohort decreased compared with the Western medicine cohort(P<0.05).Compared with 28 days of treatment,the NIHSS and mRS scores of the patients in both cohorts decreased after 6 months,while the Barthel index score increased;compared with the Western medicine cohort,patients in the integrated Chinese and Western medicine cohort showed a decrease in the NIHSS and mRS scores after both 28 days of treatment and 6 months,while the Barthel index score increased(P<0.05).Conclusion Promoting blood circulation and eliminating phlegm can effectively prevent and treat hydrocephalus after intracerebral hemorrhage and does not increase the risk of bleeding within 24 hours.
罗流;李明非;何刚;雷枭;石柳;晚孝芳;卢云
成都市新津区中医医院急诊科 成都 611430成都中医药大学附属医院广元市中医医院川北医学院附属医院眉山市中医医院叙永县中医医院
中医学
脑出血后脑积水活血豁痰法中西医结合队列研究
hydrocephalus after intracerebral hemorrhagepromoting blood circulation and eliminating phlegmintegrated Chinese and Western medicinecohort study
《北京中医药大学学报》 2024 (005)
603-610 / 8
四川省科技计划项目(No.2019YFS0040);四川省中医药管理局中医药科研专项项目(No.2023zd003);四川省名中医工作室建设项目 Science and Technology Project of Sichuan Province(No.2019YFS0040)
评论